Analysts are intrested in these 5 stocks: ( ($BDX) ), ( ($SPOT) ), ( ($ARVN) ), ( ($TWLO) ) and ( ($LUMN) ). Here is a ...

Pomerantz LLP is investigating claims on behalf of investors of Arvinas, Inc. ("Arvinas" or the "Company") . Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Pliant Therapeutics (PLRX – Research Report), Design Therapeutics (DSGN – Rese ...

Fintel reports that on May 5, 2025, Truist Securities downgraded their outlook for Arvinas (NasdaqGS:ARVN) from Buy to Hold.

The firm, a prolific backer of drug startups, will use the cash to back companies working on therapeutics, medical devices ...

The state of Connecticut “WARN” site that reports such layoffs indicates that 92 of the people to be laid off are state ...

Discover why biotech stock ARVN, trading at a 70% discount to cash value, offers potential upside despite setbacks.

There's been a notable change in appetite for Arvinas, Inc. (NASDAQ:ARVN) shares in the week since its first-quarter report, with the stock down 15% to US$7.72. Revenues of 351% beat expectations by ...